This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Evaluation of Daclatasvir (DCV) in Combination Wit...
Clinical trial

Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection

Read time: 2 mins
Last updated:18th May 2018
Identifier: NCT03487848

The purpose of this study is to evaluate daclatasvir in combination with sofosbuvir given to children with chronic hepatitis C infection


Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Open-Label, Single-Arm Trial to Evaluate the Pharmacokinetics, Safety and Efficacy of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children From 3 to Less Than 18 Years of Age With GT-1 to -6 Chronic Hepatitis C (CHC) Infection
Actual Study Start Date: May 18, 2018
Estimated Primary Completion Date: April 29, 2021
Estimated Study Completion Date: February 28, 2023

Arm:
- Experimental:
Daclatasvir with Sofosbuvir

Category Value
Date last updated at source 2019-07-30
Study type(s) Interventional
Expected enrolment 30
Study start date 2018-05-18
Estimated primary completion date 2021-04-29

View full details